145 related articles for article (PubMed ID: 31902550)
1. Intranasal Ketamine for Abortive Migraine Therapy in Pediatric Patients: A Single-Center Review.
Turner AL; Shandley S; Miller E; Perry MS; Ryals B
Pediatr Neurol; 2020 Mar; 104():46-53. PubMed ID: 31902550
[TBL] [Abstract][Full Text] [Related]
2. Randomized Controlled Feasibility Trial of Intranasal Ketamine Compared to Intranasal Fentanyl for Analgesia in Children with Suspected Extremity Fractures.
Reynolds SL; Bryant KK; Studnek JR; Hogg M; Dunn C; Templin MA; Moore CG; Young JR; Walker KR; Runyon MS
Acad Emerg Med; 2017 Dec; 24(12):1430-1440. PubMed ID: 28926159
[TBL] [Abstract][Full Text] [Related]
3. Aura in some patients with familial hemiplegic migraine can be stopped by intranasal ketamine.
Kaube H; Herzog J; Käufer T; Dichgans M; Diener HC
Neurology; 2000 Jul; 55(1):139-41. PubMed ID: 10891926
[TBL] [Abstract][Full Text] [Related]
4. Ketamine as an adjuvant for treatment of cancer pain in children and adolescents.
Finkel JC; Pestieau SR; Quezado ZM
J Pain; 2007 Jun; 8(6):515-21. PubMed ID: 17434801
[TBL] [Abstract][Full Text] [Related]
5. Nonselective and NR2B-selective N-methyl-D-aspartic acid receptor antagonists produce antinociception and long-term relief of allodynia in acute and neuropathic pain.
Swartjes M; Morariu A; Niesters M; Aarts L; Dahan A
Anesthesiology; 2011 Jul; 115(1):165-74. PubMed ID: 21606828
[TBL] [Abstract][Full Text] [Related]
6. Intranasal Ketamine and Its Potential Role in Cancer-Related Pain.
Singh V; Gillespie TW; Harvey RD
Pharmacotherapy; 2018 Mar; 38(3):390-401. PubMed ID: 29396996
[TBL] [Abstract][Full Text] [Related]
7. The THINK (Treatment of Headache with Intranasal Ketamine) Trial: A Randomized Controlled Trial Comparing Intranasal Ketamine with Intravenous Metoclopramide.
Benish T; Villalobos D; Love S; Casmaer M; Hunter CJ; Summers SM; April MD
J Emerg Med; 2019 Mar; 56(3):248-257.e1. PubMed ID: 30910061
[TBL] [Abstract][Full Text] [Related]
8. Intravenous ketamine for subacute treatment of refractory chronic migraine: a case series.
Lauritsen C; Mazuera S; Lipton RB; Ashina S
J Headache Pain; 2016 Dec; 17(1):106. PubMed ID: 27878523
[TBL] [Abstract][Full Text] [Related]
9. Ameliorating treatment-refractory depression with intranasal ketamine: potential NMDA receptor actions in the pain circuitry representing mental anguish.
Opler LA; Opler MG; Arnsten AF
CNS Spectr; 2016 Feb; 21(1):12-22. PubMed ID: 25619798
[TBL] [Abstract][Full Text] [Related]
10. Prolonged analgesic effect of ketamine, an N-methyl-D-aspartate receptor inhibitor, in patients with chronic pain.
Rabben T; Skjelbred P; Oye I
J Pharmacol Exp Ther; 1999 May; 289(2):1060-6. PubMed ID: 10215688
[TBL] [Abstract][Full Text] [Related]
11. Four years' treatment with ketamine and a trial of dextromethorphan in a patient with severe post-herpetic neuralgia.
Klepstad P; Borchgrevink PC
Acta Anaesthesiol Scand; 1997 Mar; 41(3):422-6. PubMed ID: 9113190
[TBL] [Abstract][Full Text] [Related]
12. Real-world study of intranasal ketamine for use in patients with refractory chronic migraine: a retrospective analysis.
Yuan H; Natekar A; Park J; Lauritsen CG; Viscusi ER; Marmura MJ
Reg Anesth Pain Med; 2023 Dec; 48(12):581-587. PubMed ID: 37253638
[TBL] [Abstract][Full Text] [Related]
13. The NMDA receptor antagonists memantine and ketamine as anti-migraine agents.
Podkowa K; Czarnacki K; Borończyk A; Borończyk M; Paprocka J
Naunyn Schmiedebergs Arch Pharmacol; 2023 Jul; 396(7):1371-1398. PubMed ID: 36869904
[TBL] [Abstract][Full Text] [Related]
14. Chronic Opioid Therapy Modifies QST Changes After Ketamine Infusion in Chronic Pain Patients.
Maher DP; Zhang Y; Ahmed S; Doshi T; Malarick C; Stabach K; Mao J; Chen L
J Pain; 2017 Dec; 18(12):1468-1475. PubMed ID: 28802882
[TBL] [Abstract][Full Text] [Related]
15. Role of N-methyl-D-aspartate receptor antagonists in postoperative pain management.
Suzuki M
Curr Opin Anaesthesiol; 2009 Oct; 22(5):618-22. PubMed ID: 19535974
[TBL] [Abstract][Full Text] [Related]
16. Ketamine for Migraine in the Emergency Department.
Bilhimer MH; Groth ME; Holmes AK
Adv Emerg Nurs J; 2020; 42(2):96-102. PubMed ID: 32358422
[TBL] [Abstract][Full Text] [Related]
17. Ketamine for Social Anxiety Disorder: A Randomized, Placebo-Controlled Crossover Trial.
Taylor JH; Landeros-Weisenberger A; Coughlin C; Mulqueen J; Johnson JA; Gabriel D; Reed MO; Jakubovski E; Bloch MH
Neuropsychopharmacology; 2018 Jan; 43(2):325-333. PubMed ID: 28849779
[TBL] [Abstract][Full Text] [Related]
18. Effect of Intranasal Ketamine vs Fentanyl on Pain Reduction for Extremity Injuries in Children: The PRIME Randomized Clinical Trial.
Frey TM; Florin TA; Caruso M; Zhang N; Zhang Y; Mittiga MR
JAMA Pediatr; 2019 Feb; 173(2):140-146. PubMed ID: 30592476
[TBL] [Abstract][Full Text] [Related]
19. Demonstration of analgesic effect of intranasal ketamine and intranasal fentanyl for postoperative pain after pediatric tonsillectomy.
Yenigun A; Yilmaz S; Dogan R; Goktas SS; Calim M; Ozturan O
Int J Pediatr Otorhinolaryngol; 2018 Jan; 104():182-185. PubMed ID: 29287863
[TBL] [Abstract][Full Text] [Related]
20. [Intra-operative ketamine administration reduced the level of post-thoracotomy pain].
Sano M; Inaba S; Yamamoto T; Nishino T
Masui; 2005 Jan; 54(1):19-24. PubMed ID: 15717462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
